References
- 1. Levy AD, Manning MA, Miettinen MM. Soft-tissue sarcomas of the abdomen and pelvis: Radiologic-Pathologic features, Part 2 - uncommon Sarcomas. Radiographics. 2017 May-Jun; 37(3):797-812.10.1148/rg.2017160201545289028493803
- 2. Casali PG, Abecassis N, Bauer S et al. ESMO Guidelines Committee and EURACAN. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 1; 29 (Supplement_4):iv51-iv67.
- 3. Mizuno T, Susa M, Horiuchi K, Shimazaki H, Nakanishi K, Chiba K. Spontaneous Regression of Myxofibrosarcoma of the Thigh after Open Biopsy. Case Rep Oncol. 2019 May 16; 12(2):364-369. doi: 10.1159/000500504. PMID: 31182952. PMCID: PMC6547297.10.1159/000500504654729731182952
- 4. Odei B, Rwigema JC, Eilber FR et al. Predictors of Local Recurrence in Patients with Myxofibrosarcoma. Am J Clin Oncol. 2018; 41(9):827-831. doi:10.1097/COC.0000000000000382.10.1097/COC.000000000000038228640064
- 5. Look Hong NJ, Hornicek FJ, Raskin KA et al. Prognostic factors and outcomes of patients with myxofibrosarcoma. Ann Surg Oncol. 2013; 20(1):80-86. doi:10.1245/s10434-012-2572-3.10.1245/s10434-012-2572-3383742122890594
- 6. Kikuta K, Nakayama R, Yoshida A et al. A histological positive margin after surgery is correlated with high local re-recurrence rate in patients with recurrent myxofibrosarcoma. Jpn J Clin Oncol. 2017; 47(4):334-341. doi:10.1093/jjco/hyw199.10.1093/jjco/hyw19928064204
- 7. Mühlhofer HML, Lenze U, Gersing A et al. Prognostic Factors and Outcomes for Patients with Myxofibrosarcoma: A 13-Year Retrospective Evaluation. Anticancer Res. 2019; 39(6):2985-2992. doi:10.21873/anticanres.13430.10.21873/anticanres.1343031177139
- 8. Mentzel T, Calonje E, Wadden C et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996; 20(4):391-405. doi: 10.1097/00000478-199604000-00001.10.1097/00000478-199604000-000018604805
- 9. Teurneau H, Engellau J, Ghanei I, Vult von Steyern F, Styring E. High Recurrence Rate of Myxofibrosarcoma: The Effect of Radiotherapy Is Not Clear. Sarcoma. 2019; 2019:8517371. doi:10.1155/2019/8517371.10.1155/2019/8517371679121631662702
- 10. Haglund KE, Raut CP, Nascimento AF, Wang Q, George S, Baldini EH. Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma. Int J Radiat Oncol Biol Phys. 2012; 82(1):361-367. doi:10.1016/j.ijrobp.2010.08.042.10.1016/j.ijrobp.2010.08.04220951504